Outcome | Selection of SNPs | Method | #SNPs | Beta | 95% CI | p |
---|---|---|---|---|---|---|
LDL cholesterol | Genome-wide significant and functionally relevant SNPs | PCA | 47 | − 0.032 | − 0.037 to − 0.027 | < 0.001 |
Most significant SNPs | IVW | 3 | − 0.034 | − 0.039 to − 0.029 | < 0.001 | |
All genome-wide significant SNPs | PCA | 167 | − 0.033 | − 0.038 to − 0.028 | < 0.001 | |
HDL cholesterol | Genome-wide significant and functionally relevant SNPs | PCA | 47 | − 0.026 | − 0.031 to − 0.021 | < 0.001 |
Most significant SNPs | IVW†| 3 | − 0.028 | − 0.039 to − 0.016 | < 0.001 | |
All genome-wide significant SNPs* | PCA | 141 | − 0.027 | −0.032 to − 0.022 | < 0.001 | |
Total cholesterol | Genome-wide significant and functionally relevant SNPs | PCA | 47 | − 0.030 | −0.035 to − 0.026 | < 0.001 |
Most significant SNPs | IVW†| 3 | − 0.032 | − 0.040 to − 0.023 | < 0.001 | |
All genome-wide significant SNPs | PCA | 167 | − 0.028 | − 0.047 to − 0.010 | 0.003 | |
DBP | Genome-wide significant and functionally relevant SNPs | PCA | 47 | 0.006 | 0.003 to 0.009 | < 0.001 |
Most significant SNPs | IVW†| 3 | 0.008 | − 0.005 to 0.020 | 0.23 | |
All genome-wide significant SNPs* | PCA | 141 | 0.006 | 0.003 to 0.009 | < 0.001 | |
SBP | Genome-wide significant and functionally relevant SNPs | PCA | 47 | − 0.001 | − 0.004 to 0.002 | 0.62 |
Most significant SNPs | IVW†| 3 | 0.001 | − 0.008 to 0.009 | 0.90 | |
All genome-wide significant SNPs | PCA | 167 | 0.010 | − 0.007 to 0.027 | 0.24 | |
Reticulocyte count | Genome-wide significant and functionally relevant SNPs | PCA | 47 | 0.001 | − 0.022 to 0.024 | 0.93 |
Most significant SNPs | IVW†| 3 | 0.013 | − 0.001 to 0.027 | 0.08 | |
All genome-wide significant SNPs* | PCA | 141 | 0.002 | − 0.020 to 0.023 | 0.88 |